ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

345 hedge funds and large institutions have $6.15B invested in Intra-Cellular Therapies Inc. in 2024 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 121 increasing their positions, 126 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
345
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$314M
Puts
$96.1M
Net Calls
Net Calls Change

Top Buyers

1 +$65.1M
2 +$46.7M
3 +$23.5M
4
Citadel Advisors
Citadel Advisors
Florida
+$22.4M
5
Ameriprise
Ameriprise
Minnesota
+$21.2M

Top Sellers

1 -$106M
2 -$66.5M
3 -$35.3M
4
DTC
Deep Track Capital
Connecticut
-$34.4M
5
Holocene Advisors
Holocene Advisors
New York
-$24.2M
Name Holding Trade Value Shares
Change
Change in
Stake
226
$345K
227
$344K
228
$341K
229
$337K
230
$325K
231
$320K
232
$318K
233
$318K
234
$317K
235
$313K
236
$313K
237
$304K
238
$303K
239
$298K
240
$293K
241
$287K
242
$283K
243
$277K
244
$272K
245
$271K
246
$261K
247
$259K
248
$258K
249
$256K
250
$254K